113 related articles for article (PubMed ID: 29118228)
1. Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?
Lv JW; Chen YP; Zhou GQ; Liu X; Guo Y; Mao YP; Ma J; Sun Y
J Natl Compr Canc Netw; 2017 Nov; 15(11):1363-1371. PubMed ID: 29118228
[No Abstract] [Full Text] [Related]
2. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.
Tang E; Ravaud P; Riveros C; Perrodeau E; Dechartres A
BMC Med; 2015 Aug; 13():189. PubMed ID: 26269118
[TBL] [Abstract][Full Text] [Related]
3. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.
Hartung DM; Zarin DA; Guise JM; McDonagh M; Paynter R; Helfand M
Ann Intern Med; 2014 Apr; 160(7):477-83. PubMed ID: 24687070
[TBL] [Abstract][Full Text] [Related]
4. Comparison of reporting phase III randomized controlled trials of antibiotic treatment for common bacterial infections in ClinicalTrials.gov and matched publications.
Shepshelovich D; Yelin D; Gafter-Gvili A; Goldman S; Avni T; Yahav D
Clin Microbiol Infect; 2018 Nov; 24(11):1211.e9-1211.e14. PubMed ID: 29454846
[TBL] [Abstract][Full Text] [Related]
5. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
6. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.
Riveros C; Dechartres A; Perrodeau E; Haneef R; Boutron I; Ravaud P
PLoS Med; 2013 Dec; 10(12):e1001566; discussion e1001566. PubMed ID: 24311990
[TBL] [Abstract][Full Text] [Related]
7. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
Rasmussen N; Lee K; Bero L
Trials; 2009 Dec; 10():116. PubMed ID: 20015404
[TBL] [Abstract][Full Text] [Related]
8. Empirical evidence for outcome reporting bias in randomized clinical trials of acupuncture: comparison of registered records and subsequent publications.
Su CX; Han M; Ren J; Li WY; Yue SJ; Hao YF; Liu JP
Trials; 2015 Jan; 16():28. PubMed ID: 25626862
[TBL] [Abstract][Full Text] [Related]
9. Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications.
Wong EK; Lachance CC; Page MJ; Watt J; Veroniki A; Straus SE; Tricco AC
BMJ Open; 2019 Sep; 9(9):e031138. PubMed ID: 31492792
[TBL] [Abstract][Full Text] [Related]
10. Adverse event reporting in cancer clinical trial publications.
Sivendran S; Latif A; McBride RB; Stensland KD; Wisnivesky J; Haines L; Oh WK; Galsky MD
J Clin Oncol; 2014 Jan; 32(2):83-9. PubMed ID: 24323037
[TBL] [Abstract][Full Text] [Related]
11. Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials.
Dechartres A; Bond EG; Scheer J; Riveros C; Atal I; Ravaud P
BMC Med; 2016 Nov; 14(1):192. PubMed ID: 27899150
[TBL] [Abstract][Full Text] [Related]
12. Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials.
Perlmutter AS; Tran VT; Dechartres A; Ravaud P
Ann Oncol; 2017 Apr; 28(4):688-695. PubMed ID: 28011448
[TBL] [Abstract][Full Text] [Related]
13. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
[TBL] [Abstract][Full Text] [Related]
14. The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors.
Karimian Z; Mavoungou S; Salem JE; Tubach F; Dechartres A
BMC Cancer; 2020 Nov; 20(1):1128. PubMed ID: 33225901
[TBL] [Abstract][Full Text] [Related]
15. Public availability of results of trials assessing cancer drugs in the United States.
Nguyen TA; Dechartres A; Belgherbi S; Ravaud P
J Clin Oncol; 2013 Aug; 31(24):2998-3003. PubMed ID: 23878298
[TBL] [Abstract][Full Text] [Related]
16. Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study.
Paladin I; Pranić SM
BMC Med Res Methodol; 2022 Oct; 22(1):262. PubMed ID: 36199040
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials on drug-drug interactions registered in ClinicalTrials.gov reported incongruent safety data in published articles: an observational study.
Jurić D; Pranić S; Tokalić R; Milat AM; Mudnić I; Pavličević I; Marušić A
J Clin Epidemiol; 2018 Dec; 104():35-45. PubMed ID: 30081071
[TBL] [Abstract][Full Text] [Related]
18. Comparison between publicly accessible publications, registries, and protocols of phase III trials indicated persistence of selective outcome reporting.
Zhang S; Liang F; Li W
J Clin Epidemiol; 2017 Nov; 91():87-94. PubMed ID: 28757260
[TBL] [Abstract][Full Text] [Related]
19. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA
Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570
[TBL] [Abstract][Full Text] [Related]
20. Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors.
Saleh RR; Meti N; Ribnikar D; Goldvaser H; Ocana A; Templeton AJ; Seruga B; Amir E
Cancer Med; 2020 Nov; 9(21):7888-7895. PubMed ID: 32886422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
